nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP3A4—Temozolomide—skin cancer	0.177	0.233	CbGbCtD
Perhexiline—CYP3A4—Imiquimod—skin cancer	0.177	0.233	CbGbCtD
Perhexiline—CYP2D6—Vemurafenib—skin cancer	0.153	0.201	CbGbCtD
Perhexiline—CYP3A4—Vismodegib—skin cancer	0.123	0.162	CbGbCtD
Perhexiline—CYP3A4—Vemurafenib—skin cancer	0.097	0.128	CbGbCtD
Perhexiline—CYP3A4—Docetaxel—skin cancer	0.0333	0.0438	CbGbCtD
Perhexiline—Unsteadiness—Fluorouracil—skin cancer	0.0127	0.0684	CcSEcCtD
Perhexiline—CPT2—nipple—skin cancer	0.00783	0.143	CbGeAlD
Perhexiline—CPT1A—connective tissue—skin cancer	0.00585	0.107	CbGeAlD
Perhexiline—Polyneuropathy—Docetaxel—skin cancer	0.00564	0.0304	CcSEcCtD
Perhexiline—CPT2—connective tissue—skin cancer	0.00556	0.102	CbGeAlD
Perhexiline—CPT2—skin of body—skin cancer	0.00502	0.0917	CbGeAlD
Perhexiline—Weight decreased—Vismodegib—skin cancer	0.00497	0.0268	CcSEcCtD
Perhexiline—Balance disorder—Fluorouracil—skin cancer	0.00466	0.0251	CcSEcCtD
Perhexiline—CPT2—mammalian vulva—skin cancer	0.00458	0.0836	CbGeAlD
Perhexiline—CPT1A—female reproductive system—skin cancer	0.00413	0.0755	CbGeAlD
Perhexiline—CPT2—female reproductive system—skin cancer	0.00392	0.0716	CbGeAlD
Perhexiline—Extrapyramidal disorder—Temozolomide—skin cancer	0.00367	0.0198	CcSEcCtD
Perhexiline—CPT1A—head—skin cancer	0.00345	0.063	CbGeAlD
Perhexiline—Liver injury—Temozolomide—skin cancer	0.00329	0.0177	CcSEcCtD
Perhexiline—CPT2—head—skin cancer	0.00327	0.0598	CbGeAlD
Perhexiline—Weight decreased—Vemurafenib—skin cancer	0.00307	0.0165	CcSEcCtD
Perhexiline—Neuropathy peripheral—Vemurafenib—skin cancer	0.00297	0.016	CcSEcCtD
Perhexiline—Gait disturbance—Temozolomide—skin cancer	0.00283	0.0153	CcSEcCtD
Perhexiline—Decreased appetite—Vismodegib—skin cancer	0.00272	0.0146	CcSEcCtD
Perhexiline—Fatigue—Vismodegib—skin cancer	0.00269	0.0145	CcSEcCtD
Perhexiline—Gastrointestinal pain—Vismodegib—skin cancer	0.00255	0.0138	CcSEcCtD
Perhexiline—Neuropathy peripheral—Imiquimod—skin cancer	0.00253	0.0136	CcSEcCtD
Perhexiline—Abdominal pain—Vismodegib—skin cancer	0.00247	0.0133	CcSEcCtD
Perhexiline—CPT1A—lymph node—skin cancer	0.00242	0.0441	CbGeAlD
Perhexiline—CPT2—lymph node—skin cancer	0.00229	0.0419	CbGeAlD
Perhexiline—Asthenia—Vismodegib—skin cancer	0.00224	0.0121	CcSEcCtD
Perhexiline—Flushing—Imiquimod—skin cancer	0.00215	0.0116	CcSEcCtD
Perhexiline—Diplopia—Temozolomide—skin cancer	0.00201	0.0108	CcSEcCtD
Perhexiline—Vomiting—Vismodegib—skin cancer	0.00199	0.0107	CcSEcCtD
Perhexiline—Rash—Vismodegib—skin cancer	0.00197	0.0106	CcSEcCtD
Perhexiline—Dermatitis—Vismodegib—skin cancer	0.00197	0.0106	CcSEcCtD
Perhexiline—Ataxia—Temozolomide—skin cancer	0.00189	0.0102	CcSEcCtD
Perhexiline—Weight decreased—Bleomycin—skin cancer	0.00186	0.01	CcSEcCtD
Perhexiline—Nausea—Vismodegib—skin cancer	0.00186	0.01	CcSEcCtD
Perhexiline—Hepatocellular injury—Docetaxel—skin cancer	0.00184	0.00991	CcSEcCtD
Perhexiline—Syncope—Imiquimod—skin cancer	0.00181	0.00975	CcSEcCtD
Perhexiline—Loss of consciousness—Imiquimod—skin cancer	0.00177	0.00955	CcSEcCtD
Perhexiline—Muscular weakness—Temozolomide—skin cancer	0.00177	0.00954	CcSEcCtD
Perhexiline—Convulsion—Imiquimod—skin cancer	0.00175	0.00942	CcSEcCtD
Perhexiline—Ataxia—Fluorouracil—skin cancer	0.00174	0.00937	CcSEcCtD
Perhexiline—Decreased appetite—Vemurafenib—skin cancer	0.00168	0.00904	CcSEcCtD
Perhexiline—Fatigue—Vemurafenib—skin cancer	0.00166	0.00897	CcSEcCtD
Perhexiline—Muscular weakness—Fluorouracil—skin cancer	0.00163	0.00879	CcSEcCtD
Perhexiline—Shock—Imiquimod—skin cancer	0.00162	0.00873	CcSEcCtD
Perhexiline—Hyperhidrosis—Imiquimod—skin cancer	0.00159	0.00858	CcSEcCtD
Perhexiline—Weight decreased—Temozolomide—skin cancer	0.00157	0.00846	CcSEcCtD
Perhexiline—Anorexia—Imiquimod—skin cancer	0.00157	0.00846	CcSEcCtD
Perhexiline—Hepatitis—Dactinomycin—skin cancer	0.00154	0.00827	CcSEcCtD
Perhexiline—Flushing—Bleomycin—skin cancer	0.00153	0.00823	CcSEcCtD
Perhexiline—Neuropathy peripheral—Temozolomide—skin cancer	0.00152	0.00817	CcSEcCtD
Perhexiline—Insomnia—Imiquimod—skin cancer	0.00149	0.00802	CcSEcCtD
Perhexiline—Paraesthesia—Imiquimod—skin cancer	0.00148	0.00797	CcSEcCtD
Perhexiline—Decreased appetite—Imiquimod—skin cancer	0.00143	0.00771	CcSEcCtD
Perhexiline—Flushing—Dactinomycin—skin cancer	0.00142	0.00768	CcSEcCtD
Perhexiline—Fatigue—Imiquimod—skin cancer	0.00142	0.00765	CcSEcCtD
Perhexiline—Neuropathy peripheral—Fluorouracil—skin cancer	0.0014	0.00753	CcSEcCtD
Perhexiline—Hepatitis—Temozolomide—skin cancer	0.00139	0.00748	CcSEcCtD
Perhexiline—Asthenia—Vemurafenib—skin cancer	0.00138	0.00746	CcSEcCtD
Perhexiline—Gastrointestinal pain—Imiquimod—skin cancer	0.00135	0.00725	CcSEcCtD
Perhexiline—Urticaria—Imiquimod—skin cancer	0.00131	0.00705	CcSEcCtD
Perhexiline—CYP2B6—skin of body—skin cancer	0.00131	0.0239	CbGeAlD
Perhexiline—Abdominal pain—Imiquimod—skin cancer	0.0013	0.00701	CcSEcCtD
Perhexiline—Flushing—Temozolomide—skin cancer	0.00129	0.00694	CcSEcCtD
Perhexiline—Dizziness—Vemurafenib—skin cancer	0.00128	0.00688	CcSEcCtD
Perhexiline—Ataxia—Docetaxel—skin cancer	0.00126	0.00676	CcSEcCtD
Perhexiline—Vomiting—Vemurafenib—skin cancer	0.00123	0.00661	CcSEcCtD
Perhexiline—Rash—Vemurafenib—skin cancer	0.00122	0.00656	CcSEcCtD
Perhexiline—Dermatitis—Vemurafenib—skin cancer	0.00122	0.00655	CcSEcCtD
Perhexiline—Headache—Vemurafenib—skin cancer	0.00121	0.00652	CcSEcCtD
Perhexiline—Asthenia—Imiquimod—skin cancer	0.00118	0.00636	CcSEcCtD
Perhexiline—Nausea—Vemurafenib—skin cancer	0.00115	0.00618	CcSEcCtD
Perhexiline—Tremor—Temozolomide—skin cancer	0.00113	0.0061	CcSEcCtD
Perhexiline—Anorexia—Bleomycin—skin cancer	0.00111	0.00601	CcSEcCtD
Perhexiline—Dizziness—Imiquimod—skin cancer	0.00109	0.00587	CcSEcCtD
Perhexiline—CYP2B6—lymphoid tissue—skin cancer	0.00106	0.0193	CbGeAlD
Perhexiline—Paraesthesia—Bleomycin—skin cancer	0.00105	0.00566	CcSEcCtD
Perhexiline—Convulsion—Temozolomide—skin cancer	0.00105	0.00564	CcSEcCtD
Perhexiline—Vomiting—Imiquimod—skin cancer	0.00105	0.00564	CcSEcCtD
Perhexiline—Weight decreased—Docetaxel—skin cancer	0.00104	0.00562	CcSEcCtD
Perhexiline—Anorexia—Dactinomycin—skin cancer	0.00104	0.0056	CcSEcCtD
Perhexiline—Rash—Imiquimod—skin cancer	0.00104	0.00559	CcSEcCtD
Perhexiline—Dermatitis—Imiquimod—skin cancer	0.00104	0.00559	CcSEcCtD
Perhexiline—Headache—Imiquimod—skin cancer	0.00103	0.00556	CcSEcCtD
Perhexiline—CYP2B6—female reproductive system—skin cancer	0.00102	0.0186	CbGeAlD
Perhexiline—Decreased appetite—Bleomycin—skin cancer	0.00102	0.00548	CcSEcCtD
Perhexiline—Neuropathy peripheral—Docetaxel—skin cancer	0.00101	0.00543	CcSEcCtD
Perhexiline—Nausea—Imiquimod—skin cancer	0.000978	0.00527	CcSEcCtD
Perhexiline—Convulsion—Fluorouracil—skin cancer	0.000965	0.0052	CcSEcCtD
Perhexiline—Hyperhidrosis—Temozolomide—skin cancer	0.000954	0.00514	CcSEcCtD
Perhexiline—Decreased appetite—Dactinomycin—skin cancer	0.000948	0.00511	CcSEcCtD
Perhexiline—Fatigue—Dactinomycin—skin cancer	0.00094	0.00507	CcSEcCtD
Perhexiline—Anorexia—Temozolomide—skin cancer	0.00094	0.00507	CcSEcCtD
Perhexiline—Urticaria—Bleomycin—skin cancer	0.000929	0.00501	CcSEcCtD
Perhexiline—Hepatitis—Docetaxel—skin cancer	0.000923	0.00498	CcSEcCtD
Perhexiline—Insomnia—Temozolomide—skin cancer	0.000892	0.00481	CcSEcCtD
Perhexiline—Gastrointestinal pain—Dactinomycin—skin cancer	0.000892	0.00481	CcSEcCtD
Perhexiline—Paraesthesia—Temozolomide—skin cancer	0.000886	0.00477	CcSEcCtD
Perhexiline—Anorexia—Fluorouracil—skin cancer	0.000866	0.00467	CcSEcCtD
Perhexiline—Abdominal pain—Dactinomycin—skin cancer	0.000862	0.00465	CcSEcCtD
Perhexiline—Decreased appetite—Temozolomide—skin cancer	0.000858	0.00462	CcSEcCtD
Perhexiline—Flushing—Docetaxel—skin cancer	0.000857	0.00462	CcSEcCtD
Perhexiline—CYP2B6—head—skin cancer	0.000852	0.0156	CbGeAlD
Perhexiline—Fatigue—Temozolomide—skin cancer	0.000851	0.00458	CcSEcCtD
Perhexiline—Asthenia—Bleomycin—skin cancer	0.000839	0.00452	CcSEcCtD
Perhexiline—Insomnia—Fluorouracil—skin cancer	0.000822	0.00443	CcSEcCtD
Perhexiline—Paraesthesia—Fluorouracil—skin cancer	0.000816	0.0044	CcSEcCtD
Perhexiline—Gastrointestinal pain—Temozolomide—skin cancer	0.000807	0.00435	CcSEcCtD
Perhexiline—Decreased appetite—Fluorouracil—skin cancer	0.00079	0.00426	CcSEcCtD
Perhexiline—Urticaria—Temozolomide—skin cancer	0.000784	0.00422	CcSEcCtD
Perhexiline—Asthenia—Dactinomycin—skin cancer	0.000783	0.00422	CcSEcCtD
Perhexiline—Abdominal pain—Temozolomide—skin cancer	0.00078	0.0042	CcSEcCtD
Perhexiline—CYP3A4—female reproductive system—skin cancer	0.00077	0.0141	CbGeAlD
Perhexiline—CYP2D6—female reproductive system—skin cancer	0.000758	0.0138	CbGeAlD
Perhexiline—Vomiting—Bleomycin—skin cancer	0.000744	0.00401	CcSEcCtD
Perhexiline—Rash—Bleomycin—skin cancer	0.000737	0.00397	CcSEcCtD
Perhexiline—Dermatitis—Bleomycin—skin cancer	0.000737	0.00397	CcSEcCtD
Perhexiline—Urticaria—Fluorouracil—skin cancer	0.000722	0.00389	CcSEcCtD
Perhexiline—Syncope—Docetaxel—skin cancer	0.000721	0.00388	CcSEcCtD
Perhexiline—Asthenia—Temozolomide—skin cancer	0.000708	0.00381	CcSEcCtD
Perhexiline—Loss of consciousness—Docetaxel—skin cancer	0.000707	0.00381	CcSEcCtD
Perhexiline—Convulsion—Docetaxel—skin cancer	0.000696	0.00375	CcSEcCtD
Perhexiline—Nausea—Bleomycin—skin cancer	0.000695	0.00374	CcSEcCtD
Perhexiline—Vomiting—Dactinomycin—skin cancer	0.000693	0.00374	CcSEcCtD
Perhexiline—Rash—Dactinomycin—skin cancer	0.000688	0.00371	CcSEcCtD
Perhexiline—Dizziness—Temozolomide—skin cancer	0.000652	0.00352	CcSEcCtD
Perhexiline—Nausea—Dactinomycin—skin cancer	0.000648	0.00349	CcSEcCtD
Perhexiline—Shock—Docetaxel—skin cancer	0.000645	0.00348	CcSEcCtD
Perhexiline—CYP2D6—head—skin cancer	0.000633	0.0116	CbGeAlD
Perhexiline—Vomiting—Temozolomide—skin cancer	0.000627	0.00338	CcSEcCtD
Perhexiline—Anorexia—Docetaxel—skin cancer	0.000625	0.00337	CcSEcCtD
Perhexiline—Rash—Temozolomide—skin cancer	0.000622	0.00335	CcSEcCtD
Perhexiline—Dermatitis—Temozolomide—skin cancer	0.000621	0.00335	CcSEcCtD
Perhexiline—Headache—Temozolomide—skin cancer	0.000618	0.00333	CcSEcCtD
Perhexiline—Dizziness—Fluorouracil—skin cancer	0.000601	0.00324	CcSEcCtD
Perhexiline—Insomnia—Docetaxel—skin cancer	0.000593	0.0032	CcSEcCtD
Perhexiline—Paraesthesia—Docetaxel—skin cancer	0.000589	0.00317	CcSEcCtD
Perhexiline—Nausea—Temozolomide—skin cancer	0.000586	0.00316	CcSEcCtD
Perhexiline—Vomiting—Fluorouracil—skin cancer	0.000578	0.00311	CcSEcCtD
Perhexiline—Rash—Fluorouracil—skin cancer	0.000573	0.00309	CcSEcCtD
Perhexiline—Dermatitis—Fluorouracil—skin cancer	0.000573	0.00309	CcSEcCtD
Perhexiline—Decreased appetite—Docetaxel—skin cancer	0.00057	0.00307	CcSEcCtD
Perhexiline—Headache—Fluorouracil—skin cancer	0.000569	0.00307	CcSEcCtD
Perhexiline—Fatigue—Docetaxel—skin cancer	0.000566	0.00305	CcSEcCtD
Perhexiline—Nausea—Fluorouracil—skin cancer	0.00054	0.00291	CcSEcCtD
Perhexiline—Gastrointestinal pain—Docetaxel—skin cancer	0.000536	0.00289	CcSEcCtD
Perhexiline—Abdominal pain—Docetaxel—skin cancer	0.000519	0.00279	CcSEcCtD
Perhexiline—Asthenia—Docetaxel—skin cancer	0.000471	0.00254	CcSEcCtD
Perhexiline—Dizziness—Docetaxel—skin cancer	0.000434	0.00234	CcSEcCtD
Perhexiline—Vomiting—Docetaxel—skin cancer	0.000417	0.00225	CcSEcCtD
Perhexiline—Rash—Docetaxel—skin cancer	0.000414	0.00223	CcSEcCtD
Perhexiline—Dermatitis—Docetaxel—skin cancer	0.000413	0.00223	CcSEcCtD
Perhexiline—Headache—Docetaxel—skin cancer	0.000411	0.00221	CcSEcCtD
Perhexiline—Nausea—Docetaxel—skin cancer	0.00039	0.0021	CcSEcCtD
